We are just one quarter into 2022 and the Food and Drug Administration already has experienced a number of significant changes and developments.
Health care is facing a tidal wave of change—from enforcement actions around CARES Act funding to employment issues in a post-COVID workplace to questions around telehealth coverage to controversies over gender identity discrimination.
In a new webinar, Manatt Health and a panel of state leaders discuss the opportunities and challenges of state benchmarking programs, including key lessons learned, practical guidance and best practices for addressing cost growth.
In recent years, states have sought to leverage Medicaid to address social drivers of health, relying primarily on waivers for financing.
People of color face persistent disparities in access to health care coverage and treatment, quality of care, and health outcomes.
President Biden set an ambitious health care agenda in his campaign and maintained that focus as he took office.
In a new webinar series, Manatt hosts dynamic roundtables with leaders on the emerging Metaverse and Web 3 technology and innovation occurring in today's markets.
States have always been the primary regulators of their local health care markets and have increasingly used All Payer Claims Databases (APCDs) as one tool to help them make data-driven policy decisions.
In FY 2020, the Department of Justice opened 1,079 new civil health care fraud investigations and had 1,498 civil health care fraud matters pending at the end of the fiscal year.
The nation’s overdose and death epidemic continues to get worse, but policymakers and other stakeholders have yet to fully embrace evidence-based solutions to help those with a substance use disorder, patients with pain or those who need harm reduction services.